6640 Blood Bank Reagents Boise VA Medical Center
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Boise VA Medical Center, is seeking Blood Bank Reagents for transfusion services. This is a Solicitation (36C26026Q0318) for antigen and antibody specific reagents required for safely matching blood products. While the VA's description notes Ortho Clinical as the only manufacturer for automated testing reagents, market research is also being conducted to identify other qualified vendors. Responses are due by February 17, 2026, at 5:00 PM Pacific Time.
Scope of Work
The requirement is for Transfusion Medicine Reagent for testing and quality control purposes. These reagents are critical for safely matching blood products to patients requiring life-sustaining measures within the Transfusion Services Department. The effort includes providing reagents compliant with the attached Statement of Work (SOW). The VA's initial assessment indicates Ortho Clinical as the sole manufacturer providing reagents specific to their Transfusion Services automated testing.
Contract & Timeline
- Opportunity Type: Solicitation / RFP / RFQ (also includes market research elements)
- Period of Performance: April 1, 2026, to March 31, 2031 (one-year base period with four one-year option periods).
- NAICS Code: 325413 – In-Vitro Diagnostic Substance Manufacturing (Size Standard: 1,250 employees)
- Product Service Code: 6640 – Laboratory equipment and supplies
- Set-Aside: Not specified for the solicitation; however, market research is being conducted to identify various business types (SDVOSB, VOSB, 8(a), Hub Zone, WOSB, SDB, Small Business, or Large Business).
- Response Due: February 17, 2026, at 5:00 PM Pacific Time.
- Published Date: February 3, 2026.
Submission Requirements
Interested parties should submit responses via email to eric.lingenfelter@va.gov with the subject line "Boise VAMC Transfusion Medicine Reagent – Firm Name". Submissions must include:
- Completed sections C-I and a signed acknowledgement statement.
- Contractor Point of Contact information (Name, Title, Phone, Email).
- Company Information (Name, Address, SAM UEI, Tax ID Number, Business Size/Type).
- For SDVOSB/VOSB, a copy of VetCert Certification.
- Details of any Federal Supply Schedule contract or state "open market".
- Three past contracts for similar services.
- Responses to specific questions regarding SOW compliance, experience with Automated Chemistry Immunochemistry Instrumentation, and subcontractor plans. All prospective contractors must be registered in the System for Award Management (SAM).
Place of Performance
Boise VA Medical Center, Boise, ID 83702, United States.
Contact Information
Primary Point of Contact: Eric Lingenfelter (eric.lingenfelter@va.gov, 3608529861).